NovaBay Pharmaceuticals Inc. received notice from the NYSE American LLC that it has regained compliance with the exchange's continued listing standards.
The company previously received two noncompliance notices relating to stockholders' equity upon reports of losses from continuing operations or net losses for the most recent fiscal years.
The company said NYSE American will examine the company's method of financial recovery if it fails to meet any of the exchange's continued listing standards within 12 months of Dec. 7. NYSE American can also deem NovaBay to be out of compliance if its market cap falls below $50 million on a 30-trading-day average.
